Last reviewed · How we verify

NCT04945863

COVID-19 in Nursing Homes 2020 and 2021

Completed Last updated 7 July 2021
What this trial tests

trial in Comorbidities and Coexisting Conditions in 258 participants. Completed in 18 April 2021.

Timeline
31 March 2020
Primary endpoint
18 April 2021
18 April 2021

Quick facts

Lead sponsorLena Nilsson
StatusCompleted
Study typeOBSERVATIONAL
Enrollment258
Start date31 March 2020
Primary completion18 April 2021
Estimated completion18 April 2021
Sites1 location across Sweden

Conditions studied

Sponsor

Lena Nilsson — full company profile →

Who can join

Eligibility, any sex, with Comorbidities and Coexisting Conditions or Frailty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To describe the effect on mortality in nursing home facilities during three separate equally long periods during the pandemic and more specifically to analyse the effect on mortality of improved preventive routines and vaccination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Comorbidities and Coexisting Conditions

Currently open trials in the same condition.

Other Lena Nilsson trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04945863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing